Prime Minister, Shri Narendra Modi, today reviewed the preparedness of Covid-19 vaccine delivery, distribution, and administration. Prime Minister appreciated the efforts of innovators, scientists, academicians, and pharma-companies in their efforts to develop vaccines and has directed that every effort should be made to facilitate the research, development, and manufacturing of the vaccine.
Reviewed various issues like prioritisation of population groups, reaching out to HCWs, cold-chain Infrastructure augmentation, adding vaccinators and tech platform for vaccine roll-out.
— Narendra Modi (@narendramodi) November 20, 2020
Five vaccines are in advanced stages of development in India, out of which 4 are in Phase II/III and one is in Phase-I/II. Countries such as Bangladesh, Myanmar, Qatar, Bhutan, Switzerland, Bahrain, Austria, and South Korea – have shown keen interest in partnering for vaccine development of Indian vaccines and use thereof.
In an effort to administer the vaccine at the first available opportunity, a database of healthcare and frontline workers, augmentation of cold chains, and procurement of syringes, needles, etc. are in advanced stages of preparation.
The vaccination supply chain is being enhanced and non-vaccine supplies are being escalated. Medical and nursing students and faculty will be involved in the training and implementation of the vaccination program. Every step is being steadily put in place to ensure that vaccines reach every location and person according to the prioritization principles.
The Prime Minister has directed me to work in collaboration with all reputed national and international institutions and regulators to ensure the rigor and highest global standards in Indian research and manufacturing.
National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) in consultation with State Governments and all relevant stakeholders has accelerated the implementation of vaccination of priority groups in the first phase.
The digital platform for vaccine administration and distribution is prepared and test runs underway in partnership with the State and District Level stakeholders.
The Prime Minister reviewed the aspects of emergency use authorization and for manufacture and procurement of medicine. As the results of these Phase III trials from national and international vaccines arrive, our robust and independent regulators will speedily and rigorously examine these for according authorization for use.
The Government has provided assistance of Rs 900 crore under Covid Suraksha Mission to support the Research & Development of Covid-19 vaccination.
The Prime Minister directed that a time-bound plan be laid out for speedy regulatory clearances and timely procurement for early rollout of the vaccination drive.
The Prime Minister appreciated comprehensive efforts at vaccine development. He also emphasized that given the persisting pandemic scenario there is no place for any relaxation in preventive measures such as wearing masks, keeping distance, and ensuring hygiene.
The meeting was attended by Principal Secretary to PM, Cabinet Secretary, Member (Health) NITI Aayog, Principal Scientific Advisor, Secretary Health, DG ICMR, officers of PMO, and Secretaries of related Departments of Government of India.